Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ·Healthcare·Biotechnology
$1.80
-6.74%
Mkt Cap $6.34M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$225.00
Range $225.00 – $225.00
Implied Upside
+12400.0%
Consensus $225.00 vs current $1.80